Local
Alume Nearing Potential Approval of Nerve Illumination Drug
A Roundtable is a way to meet new people and discuss this article in person at a local coffee shop or other venue.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Source: San Diego Business Journal

-Advertisement- HomeLife Science Biotechenews Alume Nearing Potential Approval of Nerve Illumination Drug BIOTECH: FDA Reviewing Co.’s Solution to Nerve Damage Caused During Surgeries By Eli Walsh November 17, 2026 Alume Bioscience co-founder and CEO Dr. Quyen Nguyen (center) is a professor of otolaryngology and pharmacology at the UC San Diego School of Medicine and a practicing otolaryngologist and surgeon. Photo courtesy Alume SAN DIEGO – Alume Biosciences can see the light at the end of the tunnel.Subscribe to keep readingThis article is for San Diego Business Journal subscribers. Subscribe for full access, or log in if you already subscribe.SubscribeSubscriber log inChecking your subscription… Previous articleHappyCo Exposes Truth Behind a PropertyNext articleDesign for the Neighbors: What San Diego Can Learn from Placemaking Elsewhere Eli WalshEli is an award-winning reporter primarily covering the tech and life sciences industries.
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at San Diego Business Journal


